According to researchers from Georgia State University's Center for Translational Antiviral Research and the Institute for Biomedical Sciences, the composition of the gut microbiota determines how vulnerable mice are to respiratory virus infections and the severity of these infections.
A researcher at the University of Central Florida College of Medicine has created a novel, more accurate therapy for a leading source of sickness worldwide each year - acute respiratory virus infections.